Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
Clinical trial NCT05199311 · SUSPENDED
Trial details
- NCT number
- NCT05199311
- Sponsor
- Hackensack Meridian Health
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2027-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.